WATSON 410 50 mg Pill - beige white capsule/oblong, 14mm
Pill with imprint WATSON 410 50 mg is Beige / White, Capsule/Oblong and has been identified as Doxycycline Monohydrate 50 mg. It is supplied by Watson Pharmaceuticals.
Doxycycline is used in the treatment of Acne; Actinomycosis; Amebiasis; Anthrax; Ocular Rosacea and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 410 50 mg
Doxycycline Monohydrate
- Imprint
- WATSON 410 50 mg
- Strength
- 50 mg
- Color
- Beige / White
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00591-0410 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
ferrosoferric oxide,
ferric oxide red,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "WATSON 410 50 mg"
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,623)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
- Doxycycline drug information
- Doxycycline Capsules (Rosacea)
- Doxycycline Delayed-Release Tablets
- Doxycycline Injection
- Doxycycline Suspension
Other brands
Vibramycin, Monodox, Doxy 100, Vibra-Tabs, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (EENT) (AHFS Monograph)
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doxy 100, Doryx, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.